RIYADH, SAUDI ARABIA
AUGUST 11, 2020 to AUGUST 12, 2020
Forum Booklet
Watch the Forum

COVID-19 Vaccines:
Global Challenges
and Prospects

November 4-5, 2020 RIYADH, SAUDI ARABIA

Virtual Forum

Organized by

In Collaboration with

Scientific Media Partner

Sponsors

Welcome Message

Bandar AlKnawy, MD, FRCPC Chief Executive Officer, Ministry of National Guard-Health Affairs
President, King Saud Bin Abdulaziz University
for Health Sciences

I am honored to welcome you to the 11th Annual Forum for Medical Research: “COVID-19 Vaccine: Global Challenges & Prospects forum.” The event is one of the most important events in its field in this year. It aims to bring together leaders in the field of COVID-19 vaccine development and production, health institutions, academic institutions, businesses and world organizations to discuss the latest updates on COVID-19 vaccine development and possible availability to the public.

This two-day global forum is structured to represent all aspects of the vaccines in development for COVID-19 to ensure global participation from experts, decision makers, news agencies, health workers and the public in general. We thank the speakers who accepted to present, collaborators, sponsors and the organizing committee members of the event.

We are looking forward to seeing you all on the 4th-5th of November 2020.

Dr. Ahmed Alaskar Executive Director, KAIMRC
President of 11th KAIMRC Annual Forum for Medical Research

On behalf of King Abdullah International Medical Research Center (KAIMRC), it is an honor to welcome you to the 11th Annual Forum for Medical Research with the theme “COVID-19 Vaccine: Global Challenges & Prospects Forum”.

KAIMRC organized the forum to review the status of vaccine development in the context of the current COVID-19 pandemic. The event is unique and significant, enabling the scientific community, health workers, governmental and non-governmental institutions and the public to be informed regarding the progress of COVID-19 vaccines, and discuss concerns and issues.

More

Dr. Mohamed Boudjelal COVID19 Forum Chairperson

We would like to welcome you attend the “COVID-19 Vaccine: Global Challenges and Prospects”.

We believe this forum is vital and the most awaited event by all in such, individuals, health providers, scientists, decision makers and charities would benefit from the presentations and discussions to be carried out, to make the right choice of the vaccines and learn how to access to them. The COVID19 forum is one stop shop to review the front runners of these vaccines to be presented by the original developers.

More

Dr. Naif Alharbi Forum Co-Chairman
Director, Vaccine Development Unit King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia

It is an immense honour to welcome people from all over the world to our global event that will highlight the international efforts for reaching a vaccine for COVID-19 pandemic.

This is the annual KAIMRC forum that comes this year focusing on “COVID-19 Vaccine: Global Challenges and Prospect”. It brings together many of the international pharmaceutical and academic vaccine developers to discuss what the humanity has achieved so far on fighting the pandemic through vaccine development. It is unprecedented time of history to have a number of vaccines in phase III clinical testing only within a year from discovering the causing virus of the pandemic and we will be glad to host this discussion in the forum.

More

Dr. Ahmed M. Salman Forum Co-Chairman
BSc, MSc, DPhil (Oxon)
Senior Immunologist-Vaccinologist at The Jenner Institute, University of Oxford.
Fellow and Advisor of Clinical Medicine at Kellogg College and Immunology Instructor at University of Oxford, UK.

The global catastrophic impact of COVID-19 pandemic calls for the urgent development of safe and effective vaccines against the virus. Researchers worldwide are moving at unprecedented speed to identify and develop viable vaccine candidates hoping to curtail the pandemic.

On behalf of our organizing committee members, prestigious sponsors and bright speakers; I am very pleased and honoured to welcome you to attend the “COVID-19 Vaccine: Global Challenges and Prospects” virtual conference.

More

About Us

We are leading scientists, health providers, entrepreneurs, regulators and humanitarian workers who have coordinated in organizing this global forum. We aim to educate the population and decision makers on the best COVID19 vaccines to consider based on scientific facts and to urge vaccine producers to care about the low-income populations and countries when pricing and distributing these vaccines.

Vision

Scientifically Driven Decision on Best COVID19 Vaccines to Consider and Lessons Learnt; Public Health Comes First.

Mission

The Forum aims to be the hub for the leading COVID19 vaccines scientists, regulators, developers and distributors to conclude on the best vaccines to use and the appropriate path for its global distribution and pricing.

Objectives of the Forum REVIEW

  • Review the current COVID19 vaccines and therapeutics being developed, the clinical trials data and associated challenges
  • Enable the scientific community, clinicians, decision makers, businesses and leaders to address concerns about these vaccines and discuss them directly with the producers.
  • Verify the integrity of the published data and claims about these vaccines through discussion, presentation and questions directly addressed to the scientists and clinicians developing these vaccines.
  • Intuitive discussion on challenges facing the global distribution of the COVID19 vaccines and to care about the low-income population and countries when pricing and distributing the COVID19 vaccines.
  • Enhance public confidence of the COVID19 vaccines on the routes that are being taken to develop them to save lives and give expert opinions on their efficacy and safety
  • Wake up call to all decision’s makers to invest in BioHealth research to serve better their populations.

President

Dr. Ahmed Alaskar

Executive Director, KAIMRC
President of 11th KAIMRC Annual Forum for Medical Research

Forum Speakers

Institute for Immunity, Transplantation and Infection Stanford University School of Medicine.

Prof. Bali Pulendran

Institute for Immunity, Transplantation and Infection Stanford University School of Medicine.
Medicine Harvard Medical School Ragon Institute of MGH, MIT, and Harvard, Director, Center for Virology and Vaccine Research, USA.

Prof. Dan Barouch

Medicine Harvard Medical School Ragon Institute of MGH, MIT, and Harvard, Director, Center for Virology and Vaccine Research, USA.
Faculty of Medicine, Department of Infectious Disease, Imperial College

Prof. Robin Shattock

Faculty of Medicine, Department of Infectious Disease, Imperial College
Director, Gamaleya National Research Center for Epidemiology and Microbiology, Academician of the Russian Academy of Sciences

Professor Aleksandr GINTSBURG

Director, Gamaleya National Research Center for Epidemiology and Microbiology, Academician of the Russian Academy of Sciences
Deputy Director for Science, Gamaleya National Research Center for Epidemiology and Microbiology, Corresponding Member of the Russian Academy of Sciences, Doctor of Biological Sciences

Dr. Denis LOGUNOV

Deputy Director for Science, Gamaleya National Research Center for Epidemiology and Microbiology, Corresponding Member of the Russian Academy of Sciences, Doctor of Biological Sciences
Senior Vice President R&D at Inovio Pharmaceuticals Inc.San Diego, California.

Dr. Kate Broderick

Senior Vice President R&D at Inovio Pharmaceuticals Inc.San Diego, California.
CEO of SudairPharma, Riyadh, KSA.

Dr. Yasser Al Obaidaa

CEO of SudairPharma, Riyadh, KSA.
Founder and Chairman, Bring Hope Humanitarian Foundation, MINC.

Dr. Mariwan Baker

Founder and Chairman, Bring Hope Humanitarian Foundation, MINC.
Jenner Institute, University of Oxford

Prof. Sarah C. Gilbert

Jenner Institute, University of Oxford
Director of medical research at KSMC and the chair of ID scientific, Committee, Kingdom of Saudi Arabia.

Prof. Ziyad Memesh

Director of medical research at KSMC and the chair of ID scientific, Committee, Kingdom of Saudi Arabia.
Senior Program Officer, Vaccines & Human Immunobiology at Bill & Melinda Gates Foundation, Seattle, WA, USA.

Dr. Holger Kanzler

Senior Program Officer, Vaccines & Human Immunobiology at Bill & Melinda Gates Foundation, Seattle, WA, USA.
CEPI, A global coalition for a global problem, General counsel & Head of Business Development.

Mr. Richard Wilder

CEPI, A global coalition for a global problem, General counsel & Head of Business Development.
Jazan University in Saudi Arabia China

Dr. Abdullah Algaissi

Assistant Professor in Virology and Vaccinology
University of Jazan/ Visiting at University of Texas Medical Branch.
Chief Medical Officer, Moderna, Affiliation

Dr. Tal Zaks

Chief Medical Officer, Moderna
Deputy Director, Vaccine Research Center, Chief, Viral Pathogenesis, NIH, USA.

Prof. Barney S. Graham

Deputy Director, Vaccine Research Center, Chief, Viral Pathogenesis, NIH, USA.
Institute of Microbiology, Chinese Academic of Sciences, China.

Prof. Lianpan Dai

Institute of Microbiology, Chinese Academic of Sciences, China.
Assistant Professor in Microbiology, Imam Abdulrahman Alfaisal University, Dammam.

Dr. Iman Almansour

Assistant professor at the Department of Epidemic Diseases Research Imam Abdulrahman Bin Faisal University
Director of Vaccine Development, King Abdullah International Medical Research. Center, Riyadh, Saudi Arabia

Dr. Naif Alharbi

Forum Co-Chairman
Director of Vaccine Development, King Abdullah International Medical Research. Center, Riyadh, Saudi Arabia
Institute of Microbiology, Chinese Academic of Sciences, China.

Dr. Anwar Hashem

Deputy Director and Associate Professor in Immunoglogy, King Fahad Medical Research Center (KFMRC), King Abdulaziz University
Dean, National School of Tropical Medicine Professor, Departments of Pediatrics, Molecular Virology & Microbiology Co-Head, Section of Pediatric Tropical Medicine, Health Policy Scholar, Baylor College of Medicine.

Prof. Peter Hotez, MD, PhD, FASTMH, FAAP

Dean, National School of Tropical Medicine
Professor, Departments of Pediatrics, Molecular Virology & Microbiology
Co-Head, Section of Pediatric Tropical Medicine, Health Policy Scholar, Baylor College of Medicine.
Associate Dean of the National School of Tropical Medicine
Professor of Pediatrics and Co-director of Texas Children’s Center for Vaccine Development at Baylor College of Medicine in Houston
Texas

Maria Elena Bottazzi

Associate Dean of the National School of Tropical Medicine
Professor of Pediatrics and Co-director of Texas Children’s Center for Vaccine Development at Baylor College of Medicine in Houston
Texas
Associate Dean of the National School of Tropical Medicine
Professor of Pediatrics and Co-director of Texas Children’s Center for Vaccine Development at Baylor College of Medicine in Houston
Texas

Professor Adrian Hill

Director of the Jenner Institute
Lakshmi Mittal and family Professor of Vaccinology
Fellow of Magdalen College, Oxford University
Vice President
Medical Affairs Therapy Area Strategy for Janssen EMEA.

Dr Catherine Taylor

Vice President
Medical Affairs Therapy Area Strategy for Janssen EMEA.
Assistant Professor of Pharmaceutical Biotechnology
King Saud University, College of Pharmacy ,Riyadh, Saudi Arabia

Mashal M. Alshazi, B.Pharm, Ph.D.

Assistant Professor of Pharmaceutical Biotechnology
King Saud University, College of Pharmacy ,Riyadh, Saudi Arabia

Forum Topics

Forum Program

  • Day 01

    4 November 2020

  • Day 02

    5 November 2020

COVID19 Vaccines Efficacy and Current Status
Opening Ceremony
13:00 - 13:30
Riyadh Time
(GMT+3)

Welcome Remarks

H.E. Bandar AlKnawy, MD, FRCPC

Chief Executive Officer, Ministry of National Guard-Health Affairs
President, King Saud Bin Abdulaziz University for Health Sciences

Dr. Ahmed Alaskar

Executive Director, King Abdullah International Medical Research Center

Margaretta Colangelo

Co-Founder & Managing Director, Deep Knowledge Group, San Francisco

Dr. Mohamed Boudjelal

Forum Chairman, KAIMRC

Keynote Presentation
13:40 - 14:30
Riyadh Time
(GMT+3)

Chair-Moderator

Dr. Majed Al Ghoribi

Chairman Infectious Diseases Research Department KAIMRC, KSA.

Systems biological analysis of immunity to infection and vaccination

Prof Bali Pulendran

Institute for Immunity, Transplantation and Infection Stanford University School of Medicine

Discussion

(20 min)

Track: Non-Replicating Viral Vector Vaccines
14:40-16:20
Riyadh Time
(GMT+3)

Chair

Dr. Ahmed M. Salman

Forum Co-Chairman
BSc, MSc, DPhil (Oxon)
Senior Immunologist-Vaccinologist at The Jenner Institute, University of Oxford.
Fellow and Advisor of Clinical Medicine at Kellogg College and Immunology Instructor at University of Oxford, UK.

Oxford-AstraZeneca Vaccine: Development of the ChAdOx1 nCoV-19/AZD1222 vaccine

(20 min)

Professor Sarah Gillbert

Vaccinology in the Nuffield Department of Medicine at the University of Oxford

BIDMC and Johnson & Johnson (J&J) Vaccine:
An Ad26 Vector-Based Vaccine for SARS-CoV-2

(20 min)

Prof. Dan Barouch

Medicine Harvard Medical School Ragon Institute of MGH, MIT, and Harvard, Director, Center for Virology and Vaccine Research, USA

Russian: Sputnik V - The First Registered Human Adenovirus Vector-Based COVID-19 Vaccine

(20 min)

Professor Aleksandr GINTSBURG

Director, Gamaleya National Research Center for Epidemiology and Microbiology
Academician of the Russian Academy of Sciences

Dr. Denis LOGUNOV

Deputy Director for Science
Gamaleya National Research Center for Epidemiology and Microbiology Corresponding Member of the Russian Academy of Sciences Doctor of Biological Sciences

Discussion

(30 min)

Track: RNA based vaccines
16:30 - 17:30
Riyadh Time
(GMT+3)

Chair

Margaretta Colangelo

Co-Founder & Managing Director, Deep Knowledge Group, San Francisco

RNA Vaccine:
Self-amplifying RNA Covid-19 vaccine - Update and potential advantages

(20 min)

Prof. Robin Shattock

Faculty of Medicine, Department of Infectious Disease, Imperial College

NIH Vaccine:
Prototype Pathogen Approach for Pandemic Preparedness: Applying New Technologies for Vaccine Antigen Design and Platform Manufacturing to Address COVID-19

(20 min)

Barney S. Graham, MD, PhD

Deputy Director, Vaccine Research Center, Chief, Viral Pathogenesis

Discussion

(20 min)

Track: DNA/Protein based vaccines
17:40 - 18:40
Riyadh Time
(GMT+3)

Chair

Dr. Julia Michelotti

MRIGlobal, USA

Zhiefie Vaccine:
Development of betacoronavirus vaccines against COVID-19, MERS and SARS, Anhui Zhifei Longcom Biopharmaceutical

(20 min)

Prof. Lianpan Dai

Institute of Microbiology, Chinese Academic of Sciences, China

Inovio COVID19 Vaccine

(20 min)

Dr. Kate Broderick

Senior Vice President R&D at Inovio Pharmaceuticals Inc. San Diego, California

Discussion

(20 min)

Track: Other Virus based Vaccines
18:50 - 20:20
Riyadh Time
(GMT+3)

Chair

Manal Alaamery, PHD

Chairman of Innovation and Entrepreneurship Department KAIMRC, MNGHA, KSAs

MODERNA : The Development of mRNA-1273 to Prevent COVID-19

(20 min)

Dr. Tal Zaks

Chief Medical Officer, Moderna

Johnson & Johnson COVID-19 Vaccine

(20 min)

Dr. Catherine Taylor

Vice President, EMEA Medical Affairs, Therapy Area Strategy at Janssen Europe, Middle East & Africa (EMEA)

Baylor-India Vaccine: A Yeast-derived COVID-19 Recombinant Protein Vaccine for Global Health

(20 min)

Prof. Maria Elena Bottazzi

Associate Dean, National School of Tropical Medicine, Co-Section Head, Pediatric Tropical Medicine Professor, Pediatrics & Molecular Virology & Microbiology Baylor College of Medicine and Texas Children’s Hospital

Discussion

(30 min)

Panel Discussion and Recommendations
20:30 - 21:00
Riyadh Time
(GMT+3)

Dr. Mohamed Boudjelal

KAIMRC, KSA


Dr. Ahmed M. Salman

Forum Co-Chairman
BSc, MSc, DPhil (Oxon)
Senior Immunologist-Vaccinologist at The Jenner Institute, University of Oxford.
Fellow and Advisor of Clinical Medicine at Kellogg College and Immunology Instructor at University of Oxford, UK.

Margaretta Colangelo

Co-Founder & Managing Director, Deep Knowledge Group, San Francisco

Track: Saudi Academic Efforts for COVID-19 Sciences and Vaccines
14:00-15:30
Riyadh Time
(GMT+3)

Chair

Dr. Majed Aljeraisy

Chairman of Research Office, Director of Clinical Trials Services

KAIMRC/Oxford MERS Vaccine Development:
Setting the stage for COVID-19 Vaccine development.

(15 min)

Dr. Naif Alharbi

Director of Vaccine Development, King Abdullah Internatinal Medical Research Center, Riyadh, Saudi Arabia

Rapid Development of several SARS-CoV-2 vaccines based on recombinant plasmid DNA and adenovirus vector serotype 5

(15 min)

Dr. Anwar Hashem

Deputy Director and Associate Professor in Immunoglogy, King Fahad Medical Research Center (KFMRC), King Abdulaziz University

Serological evaluation and impact on COVID-19 vaccines

(15 min)

Dr. Abdullah Algaisi

Assistant Professor in Virology and Vaccinology, University of Jazan/ Visiting at University of Texas Medical Branch.

Newly developed pDNA vaccine for COVID-19

(15 min)

Dr. Iman Almansour

Assistant professor at the Department of Epidemic Diseases Research Imam Abdulrahman Bin Faisal University

Development of mRNA based vaccine candidate against COVID19

(15 min)

Mashal M. Alshazi, B.Pharm, Ph.D.

Assistant Professor of Pharmaceutical Biotechnology
King Saud University, College of Pharmacy ,Riyadh, Saudi Arabia

Discussion

(15 min)

Track: Accessibility to the Vaccine
15:40-17:10
Riyadh Time
(GMT+3)

Chair

Dr. Faisal Almajed

General Director – University Relations and Media Affairs, King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA

CEPI and CoVax initiative to advance vaccine accessibility

(20 min)

Mr. Richard Wilder

CEPI, A global coalition for a global problem, General counsel & Head of Business Development

Challenges in Distributing COVID19 Vaccine to People in Need

(20 min)

Dr. Mariwan Baker, PhD

Founder and Chairman, Bring Hope Humanitarian Foundation, MINC

Global response to COVID-19

(20 min)

Dr. Holger Kanzler

Program Officer at Bill & Melinda Gates ,Foundation, Seattle, Washington

Discussion

(30 min)

Track: Challenges Facing COVID19 Selection and Vaccination
17:20-18:50
Riyadh Time
(GMT+3)

Chair

Dr. Gene Garrard Olinger

Principal Advisor, Science; Global Health Surveillance & Diagnostic Division

Principle to Select Best Vaccine to Acquire

(20 min)

Prof. Ziyad Memesh

Director of medical research at KSMC and the chair of ID scientific, Committee, Kingdom of Saudi Arabia

SUDAIRPHARMA

(20 min)

Dr. Yasser Al Obaidaa

CEO of SudairPharma, Riyadh, KSA

COVID-19 Vaccines in a Time of Anti-Science Disinformation

(20 min)

Peter Hotez, MD, PhD, FASTMH, FAAP

Dean, National School of Tropical, Medicine, Professor, Departments of Pediatrics, Molecular Virology & Microbiology, Co-Head, Section of Pediatric Tropical Medicine, Health Policy, Scholar, Baylor College of Medicine

Discussion

(30 min)

19:00 - 20:00
Riyadh Time
(GMT+3)

CLOSING Presentation

Prof. Faith Osier

Professor of Immunology, Heidelberg University Hospital, Germany and KEMRI-Wellcome Trust, Kenya

Some Learnings from COVID-19 for vaccines

(30 min)

Professor Adrian Hill

Director of the Jenner Institute
Lakshmi Mittal and family Professor of Vaccinology
Fellow of Magdalen College, Oxford University

Closing Remarks

Organizing Committee Members


  • Day 01

    4 November 2020

  • Day 02

    5 November 2020

Organizers

Sponsors

IN COLLABORATION WITH

Scientific Media Partner

ORGANIZING Committee & Moderators

Dr. Mohamed Boudjelal
Forum Chairperson
Director Drug Discovery and Development
Chairman of Medical Research Core Facility KAIMRC-Ministry National Guard Health Affairs
Riyadh, Kingdom of Saudi Arabia
Dr. Faisal Almajed
General Director - University Relations and Media Affairs
Director – King Abdullah Arabic Health Encyclopedia (KAAHE)
Assistant Professor – Molecular Medical Microbiology
King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA
Dr. Ahmed M. Salman
BSc, MSc, DPhil (Oxon)
Senior Immunologist-Vaccinologist at The Jenner Institute, University of Oxford.
Fellow and Advisor of Clinical Medicine at Kellogg College and Immunology Instructor at University of Oxford, UK.
Dr. Gene Garrard Olinger
Principal Advisor, Science; Global Health Surveillance & Diagnostic Division
Margaretta Colangelo
Co-Founder & Managing Director Deep Knowledge Group, San Francisco, California
Dr Mariwan Baker
Founder and Chairman, Bring Hope Humanitarian Foundation, SWEDEN
DR. BARRAK AL SOMAIE
Operations Director, King Abdullah International Medical Research Center (KAIMRC) Ministry of National Guard - Health Affairs (MNG-HA), Riyadh, Kingdom of Saudi Arabia
Dr. Bader Aldebasi
Assistant Professor of Radiology, College of Applied Medical Science, KSAU-HS Deputy Head of Research Training & Development Section, KAIMRC, Riyadh
Dr. Ibraheem A. Bushnak
Head of Research Training & Development Section, KAIMRC, Riyadh
Head and Research Scientist of Nanomedicine Department, KAIMRC, Riyadh
Dr. Naif Alharbi
Forum Co-Chairman
Director of Vaccine Development, King Abdullah Internatinal Medical Research Center, Riyadh, Saudi Arabia
Dr. Julia Michelotti
Principal Scientist,
MRIGlobal,
USA
Dr. Abdelali Haoudi
Managing Director, Medical Biotechnology Park
Head, Strategy and Business Development
King Abdullah International Medical Research Center
Riyadh, Kingdom of Saudi Arabia
Dr. Majed Al Jeraisy
Chairman of Research Office
Director of Clinical Trials Services
Manal Alaamery, PhD
Chairman of Innovation and Entrepreneurship Department KAIMRC
MNGHA, KSA
Dr. Majed Al Ghoribi
Chairman, Infectious Disease Research Department at King Abdullah International Medical Research Center
(كيمارك KAIMRC) Kingdom of Saudi Arabia
Prof. Faith Osier
Professor of Immunology
Heidelberg University Hospital
Germany and KEMRI-Wellcome Trust, Kenya
Address

King Abdullah International Medical Research Center (KAIMRC)
Ministry of National Guard - Health Affairs
P.O. Box 3660, Riyadh 11481 Mail Code 1515